Mutational analysis of RAD51 in 125 families from 12 countries across Europe and North American found an association between RAD51C/D mutations and increased risk of ovarian cancer (RAD51C: p < 0.001, RAD51D: p < 0.001) [101]. Here, RAD51 is linked to ovarian carcinoma.